Arugomycin, a new anthracycline antibiotic. I. Taxonomy, fermentation, isolation and physico-chemical properties. 1987

H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
Institute of Applied Microbiology, University of Tokyo, Japan.

Arugomycin (AGM) is a new anthracycline antibiotic produced by strain No. 1098-AV2 which was identified as Streptomyces violaceochromogenes. AGM was isolated by solvent extraction, silicic acid chromatography and Sephadex LH-20 column chromatography. Acid treatment of AGM gave the chromophore, named arugorol, which was identified as 4'-epi-nogalarol, and sugar moieties. AGM inhibited the growth of Gram-positive bacteria and showed antitumor activity against sarcoma S-180 and Ehrlich ascites tumors.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D009279 Naphthacenes Polyacenes with four ortho-fused benzene rings in a straight linear arrangement. This group is best known for the subclass called TETRACYCLINES. Tetracenes,Benz(b)Anthracenes
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.

Related Publications

H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
November 1994, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
January 1990, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
February 2000, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
October 1994, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
June 1987, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
January 1990, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
March 1986, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
November 1999, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
November 1989, The Journal of antibiotics,
H Kawai, and Y Hayakawa, and M Nakagawa, and K Furihata, and K Furihata, and A Shimazu, and H Seto, and N Otake
June 1994, The Journal of antibiotics,
Copied contents to your clipboard!